Vulvodynia is a chronic pain syndrome that may affect up to 16% of the female population.1 It is a diagnosis of exclusion based on persistent discomfort, most often described as burning pain, that is present without objective cutaneous findings and no identifiable infectious, inflammatory, neoplastic, or neurologic cause.1 Currently, no single effective therapy or consensus on treatment exists.2 We report a case of vulvodynia successfully treated with botulinum toxin A.
Tieu KD, MacGregor JL. Successful Treatment of Vulvodynia With Botulinum Toxin A. Arch Dermatol. 2011;147(2):251–252. doi:10.1001/archdermatol.2010.443
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: